Garlic Extract 100 1 - China

Garlic Extract (100: 1) (Odorless) allicin scordinin alliin Product No:

OHI-000029 Active Ingredient: allicin Specification: 100: 1 Test

Method UV-VIS

Basic Information of Garlic Extract (100: 1) (odorless)

What Is Garlic 100: 1 Extract ?

Garlic (Allium sativum), has been used nutritionally throughout history to support the cardiovascular system.

Our garlic extract have a highly concentrated, 100: 1 extract of aged odorless garlic, providing scordinin, allicin compound as well as alliin.

Uses For Garlic 100: 1 extract

Cardiovascular Support: Positive effects of garlic on the cardiovascular system include healthy blood flow and platelet function, healthy lipid and triglyceride metabolism, reduced oxidative stress, and healthy arterial function.

Immune System Support: Garlic has also demonstrated support for maintaining a healthy gut ecology and promoting healthy immune system function.

Garlic Extract 100 1

Thank you in advance for your consideration

Company Contact:

• Posted By: Changsha Organic Herb Inc

• Phone: 8673182739236

• Address: A301 International Enterprice Center, No. 188, Hua, Hunan , China

• Email:

• Website: http://www.organic-herb.com

• Business Description: Organic Herb Inc.
  
  (OHI) has been dedicated to the research and development of innovative nutraceutical ingredients since 1993 - Our commitment to science and quality control has earned OHI recognition within the industry as a trusted supplier of ingredients of the highest quality.
  
  OHI is the Developer, Manufacturer, Exporter and Primary Supplier of the most remarkable alternative and complementary herbal health products and raw material available today.
  
  OHI develops and manufactures superior nutraceutical ingredients.
  
  OHI has advanced in home lab as well as professional R&D people swift response to any of your request.
  
  We also co operates with the world's most prestigious universities and private research institutions in the biological assessment of safety and effectiveness up to clinical phase II.